Tue, May 21, 2024
Biocon Biologics on Tuesday said it has received approval from the US health regulator for its biosimilar product to treat different types of ophthalmology conditions.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.